Saccomano Nicholas A

President and CEO, DirectorOnKure Therapeutics, Inc. (OKUR) · full profile →Form 4 · filed Aug 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
0 non-derivative · 11 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2026Grant(A)150K$0150K
Aug 7, 2026Disposed to issuer(D)2K0
Aug 7, 2026Grant(A)2K2K
Aug 7, 2026Disposed to issuer(D)1K0
Aug 7, 2026Grant(A)1K1K
Aug 7, 2026Disposed to issuer(D)8K0
Aug 7, 2026Grant(A)8K8K
Aug 7, 2026Disposed to issuer(D)17K0
Aug 7, 2026Grant(A)17K17K
Aug 7, 2026Disposed to issuer(D)542K0
Aug 7, 2026Grant(A)542K542K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001609284-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about OKUR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001609284-26-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at OnKure Therapeutics, Inc.
over the last 90 days and cite the filings.